Skip to main content

IN8bio

  • | Biotech or pharma, therapeutic R&D
IN8bio, Inc. (“IN8bio”) is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers using allogeneic, autologous and genetically modified gamma-delta T cells.

Address

New York
New York
United States
Visit website

Contact Exhibitor


Loading
View all Exhibitors
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors